Impact of intraoperative allogenic and autologous transfusion on immune function and prognosis in patients with hepatocellular carcinoma

Medicine (United States)

Volumn 99, Issue 41, 2020, Pages

  Gong, Youwei ^a   Tang, Yonglian ^a   Xue, Yinghong ^a   Chen, Ling ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

allogeneic transfusion; autologous transfusion; hepatocellular carcinoma; immune function; prognosis

Indexed keywords

IMMUNOGLOBULIN;

BLOOD AUTOTRANSFUSION; BLOOD TRANSFUSION; FEMALE; HUMAN; IMMUNOLOGY; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; MIDDLE AGED; NATURAL KILLER CELL; PEROPERATIVE CARE; PROGNOSIS; T LYMPHOCYTE SUBPOPULATION;

BLOOD TRANSFUSION; BLOOD TRANSFUSION, AUTOLOGOUS; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; IMMUNOGLOBULINS; INTRAOPERATIVE CARE; KILLER CELLS, NATURAL; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; T-LYMPHOCYTE SUBSETS;

EID: 85092685001     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000022568     Document Type: Article

References (24)

1. Bray F, Ferlay J, Soerjomataram I,. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68: 394-424.
2. Hallet J, Tsang M, Cheng ES,. The impact of perioperative red blood cell transfusions on long-term outcomes after hepatectomy for colorectal liver metastases. Ann Surg Oncol 2015; 22: 4038-45.
3. Torrance HD, Brohi K, Pearse RM,. Association between gene expression biomarkers of immunosuppression and blood transfusion in severely injured polytrauma patients. Ann Surg 2015; 261: 751-9.
4. Shander A, Lobel GP, Javidroozi M,. Transfusion practices and infectious risks. Expert Rev Hematol 2016; 9: 597-605.
5. Lopez-Aguiar AG, Ethun CG, Pawlik TM,. Association of perioperative transfusion with recurrence and survival after resection of distal cholangiocarcinoma: a 10-Institution Study from the US Extrahepatic Biliary Malignancy Consortium. Ann Surg Oncol 2019; 26: 1814-23.
6. Newman ET, Watters TS, Lewis JS,. Impact of perioperative allogeneic and autologous blood transfusion on acute wound infection following total knee and total hip arthroplasty. J Bone Joint Surg Am 2014; 96: 279-84.
7. Yamamoto Y, Yamashita T, Tsuno NH,. Safety and efficacy of preoperative autologous blood donation for high-risk pregnant women: experience of a large university hospital in Japan. J Obstet Gynaecol Res 2014; 40: 1308-16.
8. Mayer-Rollnik S, Harms C, Bernasconi L,. Evaluation of autologous retransfusion from a closed suction drainage system for patient blood management in elective total hip and knee replacement: a two cohort study. Eur J Anaesthesiol 2020; 37: 180-6.
9. Guo JR, Xu F, Jin XJ,. Impact of allogenic and autologous transfusion on immune function in patients with tumors. Asian Pac J Cancer Prev 2014; 15: 467-74.
10. Long MY, Liu ZH, Zhu JG,. Comparative analysis of autologous blood transfusion and allogeneic blood transfusion in surgical patients. Int J Clin Exp Med 2014; 7: 2889-94.
11. Cescon M, Vetrone G, Grazi GL,. Trends in perioperative outcome after hepatic resection: analysis of 1500 consecutive unselected cases over 20 years. Ann Surg 2009; 249: 995-1002.
12. Mantoani CC, Margatho AS, Dantas RAS,. Perioperative blood transfusion and occurrence of surgical site infection: an integrative review. AORN J 2019; 110: 626-34.
13. Reeh M, Ghadban T, Dedow J,. Allogenic blood transfusion is associated with poor perioperative and long-term outcome in esophageal cancer. World J Surg 2017; 41: 208-15.
14. Qiu L, Wang DR, Zhang XY,. Impact of perioperative blood transfusion on immune function and prognosis in colorectal cancer patients. Transfus Apher Sci 2016; 54: 235-41.
15. Perisanidis C, Mittlbock M, Dettke M,. Identifying risk factors for allogenic blood transfusion in oral and oropharyngeal cancer surgery with free flap reconstruction. J Oral Maxillofac Surg 2013; 71: 798-804.
16. De Oliveira GS Jr, Schink JC, Buoy C,. The association between allogeneic perioperative blood transfusion on tumour recurrence and survival in patients with advanced ovarian cancer. Transfus Med (Oxford, Engl) 2012; 22: 97-103.
17. Kuroda S, Tashiro H, Kobayashi T,. No impact of perioperative blood transfusion on recurrence of hepatocellular carcinoma after hepatectomy. World J Surg 2012; 36: 651-8.
18. Tai YH, Wu HL, Mandell MS,. The association of allogeneic blood transfusion and the recurrence of hepatic cancer after surgical resection. Anaesthesia 2020; 75: 464-71.
19. Zaw AS, Bangalore Kantharajanna S, Kumar N,. Is autologous salvaged blood a viable option for patient blood management in oncologic surgery? Transfus Med Rev 2017; 31: 56-61.
20. Zhou J,. A review of the application of autologous blood transfusion. Brazilian J Med Biol Res 2016; 49: e5493.
21. Akbulut S, Kayaalp C, Yilmaz M,. Effect of autotransfusion system on tumor recurrence and survival in hepatocellular carcinoma patients. World J Gastroenterol 2013; 19: 1625-31.
22. Sugita S, Sasaki A, Iwaki K,. Prognosis and postoperative lymphocyte count in patients with hepatocellular carcinoma who received intraoperative allogenic blood transfusion: a retrospective study. Eur J Surg Oncol 2008; 34: 339-45.
23. Piao YR, Piao LZ, Zhu LH,. Prognostic value of T cell immunoglobulin mucin-3 in prostate cancer. Asian Pac J Cancer Prev 2013; 14: 3897-901.
24. Tormey CA, Hendrickson JE,. Transfusion-related red blood cell alloantibodies: induction and consequences. Blood 2019; 133: 1821-30.